Survival After Blood Transfusion in the French Administrative Regions of Burgundy and Franche-Comté

Centre Hospitalier Universitaire de Besancon16,099 enrolled

Overview

Red blood cell transfusion (RBC) is the main symptomatic treatment for severe anemia. RBC transfusion has proven its efficacy regarding mortality and morbidity, but it is not without side effects. The infectious side effects of transfusion are largely considered under control, non-infectious side effects are taking center stage. Seeking explanations for the beneficial and deleterious effects of RBC transfusions is necessary to ensure the safe and optimal use of this precious resource. The investigators aim to study the impact of donor and RBC characteristics on patient survival.

Study Type

OBSERVATIONAL

Enrollment

16,099

Conditions

Erythrocyte Transfusion for All Conditions

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Aged 18 and over * Erythrocyte Transfusion between 2007 and 2011 * Performed at the University Hospital of Besançon or Dijon Exclusion Criteria: * Transfusion of any blood product prior to January 1st, 2007

Locations (2)

Centre d'Investigation Clinique, CHU de Besançon

Besançon, France

Survival After Blood Transfusion in the French Administrative Regions of Burgundy and Franche-Comté

Overview

Conditions

Eligibility

Locations (2)

Outcomes

Primary Outcomes